Clinical Trial Update: Metformin to Reduce Heart Failure After Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigates metformin to reduce heart failure after myocardial infarction, with completed Phase 2 and Phase 3 studies and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes
• Heart Failure
• St-elevation Myocardial Infarction

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: ST Elevation Myocardial Infarction (STEMI), Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-01-30